FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007260291> ?p ?o ?g. }

• W2007260291 endingPage "e0116341" @default.
• W2007260291 startingPage "e0116341" @default.
• W2007260291 abstract "To evaluate the clinical value of 16α-[18F]fluoroestradiol (18F-FES) PET/CT in assisting the individualized treatment decisions of breast cancer patients.Thirty-three breast cancer patients, who underwent both 18F-FES and 18F-FDG PET/CT from July 2010 to March 2013 in our center, were enrolled in this preliminary study. All the patients used 18F-FES PET/CT as a diagnostic tool with a clinical dilemma. We used the maximum Standardized Uptake Value (SUVmax) to quantify ER expression and a cutoff value of 1.5 to dichotomize results into ER positive and negative lesions. All patients were clinically followed up at least 6 months.In evaluating equivocal lesions on conventional work-up group (n = 4), three lung lesions and another iliac lesion were enrolled. As for three lung lesions, 18F-FES PET/CT showed one lesion with high uptake, which suggested it was an ER positive metastasis. The other two lesions were 18F-FES negative, which meant an ER negative metastasis or secondary primary tumor. Additionally, one iliac lesion was detected by MRI. 18F-FDG uptake was high at the suspected lesion, whereas 18F-FES uptake was absent; In predicting origin of metastasis group (n = 2), two breast cancer patients had secondary primary tumors were collected. They were 18F-FES negative, which showed low possibility of metastasis from breast cancer and they were all confirmed by biopsy. In detecting ER status in metastasis group (n = 27), 18F-FES PET/CT showed increased 18F-FES uptake in all metastatic lesions in 11 patients; absent in all lesions in 13 patients; and the remaining 3 patients had both 18F-FES positive and negative lesions. Totally, on the basis of the 18F-FES PET/CT results, we found changes in the treatment plans in 16 patients (48.5%, 16/33).18F-FES PET/CT could assess the entire tumor volume receptor status; therefore, it may be used to assist the individualized treatment decisions of breast cancer patients." @default.
• W2007260291 created "2016-06-24" @default.
• W2007260291 creator A5001215942 @default.
• W2007260291 creator A5004075936 @default.
• W2007260291 creator A5012321817 @default.
• W2007260291 creator A5021493264 @default.
• W2007260291 creator A5022138438 @default.
• W2007260291 creator A5037821827 @default.
• W2007260291 creator A5056399898 @default.
• W2007260291 creator A5075821995 @default.
• W2007260291 creator A5076480096 @default.
• W2007260291 creator A5077885718 @default.
• W2007260291 creator A5078704429 @default.
• W2007260291 date "2015-01-24" @default.
• W2007260291 modified "2023-10-14" @default.
• W2007260291 title "The Preliminary Study of 16α-[18F]fluoroestradiol PET/CT in Assisting the Individualized Treatment Decisions of Breast Cancer Patients" @default.
• W2007260291 cites W1909697168 @default.
• W2007260291 cites W1916451517 @default.
• W2007260291 cites W1970345670 @default.
• W2007260291 cites W2013373169 @default.
• W2007260291 cites W2013822060 @default.
• W2007260291 cites W2067508470 @default.
• W2007260291 cites W2088497453 @default.
• W2007260291 cites W2090954603 @default.
• W2007260291 cites W2095627442 @default.
• W2007260291 cites W2119065193 @default.
• W2007260291 cites W2135759741 @default.
• W2007260291 cites W2137478903 @default.
• W2007260291 cites W2137853125 @default.
• W2007260291 cites W2141580899 @default.
• W2007260291 cites W2151774893 @default.
• W2007260291 cites W2164457061 @default.
• W2007260291 cites W2165946747 @default.
• W2007260291 cites W2165948908 @default.
• W2007260291 cites W2166082627 @default.
• W2007260291 cites W2170273915 @default.
• W2007260291 cites W2346572707 @default.
• W2007260291 cites W4229503712 @default.
• W2007260291 doi "https://doi.org/10.1371/journal.pone.0116341" @default.
• W2007260291 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4305317" @default.
• W2007260291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25617853" @default.
• W2007260291 hasPublicationYear "2015" @default.
• W2007260291 type Work @default.
• W2007260291 sameAs 2007260291 @default.
• W2007260291 citedByCount "34" @default.
• W2007260291 countsByYear W20072602912015 @default.
• W2007260291 countsByYear W20072602912016 @default.
• W2007260291 countsByYear W20072602912017 @default.
• W2007260291 countsByYear W20072602912018 @default.
• W2007260291 countsByYear W20072602912020 @default.
• W2007260291 countsByYear W20072602912021 @default.
• W2007260291 countsByYear W20072602912022 @default.
• W2007260291 countsByYear W20072602912023 @default.
• W2007260291 crossrefType "journal-article" @default.
• W2007260291 hasAuthorship W2007260291A5001215942 @default.
• W2007260291 hasAuthorship W2007260291A5004075936 @default.
• W2007260291 hasAuthorship W2007260291A5012321817 @default.
• W2007260291 hasAuthorship W2007260291A5021493264 @default.
• W2007260291 hasAuthorship W2007260291A5022138438 @default.
• W2007260291 hasAuthorship W2007260291A5037821827 @default.
• W2007260291 hasAuthorship W2007260291A5056399898 @default.
• W2007260291 hasAuthorship W2007260291A5075821995 @default.
• W2007260291 hasAuthorship W2007260291A5076480096 @default.
• W2007260291 hasAuthorship W2007260291A5077885718 @default.
• W2007260291 hasAuthorship W2007260291A5078704429 @default.
• W2007260291 hasBestOaLocation W20072602911 @default.
• W2007260291 hasConcept C121608353 @default.
• W2007260291 hasConcept C126322002 @default.
• W2007260291 hasConcept C126838900 @default.
• W2007260291 hasConcept C142724271 @default.
• W2007260291 hasConcept C143998085 @default.
• W2007260291 hasConcept C199374082 @default.
• W2007260291 hasConcept C2775842073 @default.
• W2007260291 hasConcept C2775930923 @default.
• W2007260291 hasConcept C2775934546 @default.
• W2007260291 hasConcept C2776256026 @default.
• W2007260291 hasConcept C2779013556 @default.
• W2007260291 hasConcept C2780283643 @default.
• W2007260291 hasConcept C2781156865 @default.
• W2007260291 hasConcept C2989005 @default.
• W2007260291 hasConcept C530470458 @default.
• W2007260291 hasConcept C71924100 @default.
• W2007260291 hasConceptScore W2007260291C121608353 @default.
• W2007260291 hasConceptScore W2007260291C126322002 @default.
• W2007260291 hasConceptScore W2007260291C126838900 @default.
• W2007260291 hasConceptScore W2007260291C142724271 @default.
• W2007260291 hasConceptScore W2007260291C143998085 @default.
• W2007260291 hasConceptScore W2007260291C199374082 @default.
• W2007260291 hasConceptScore W2007260291C2775842073 @default.
• W2007260291 hasConceptScore W2007260291C2775930923 @default.
• W2007260291 hasConceptScore W2007260291C2775934546 @default.
• W2007260291 hasConceptScore W2007260291C2776256026 @default.
• W2007260291 hasConceptScore W2007260291C2779013556 @default.
• W2007260291 hasConceptScore W2007260291C2780283643 @default.
• W2007260291 hasConceptScore W2007260291C2781156865 @default.
• W2007260291 hasConceptScore W2007260291C2989005 @default.
• W2007260291 hasConceptScore W2007260291C530470458 @default.
• W2007260291 hasConceptScore W2007260291C71924100 @default.

• next